Coronary care unit and primary percutaneous coronary intervention networks improve the standard of care: reperfusion therapy in ST elevation myocardial infarction in Serbia from 2002 to 2008

2011 ◽  
Vol 12 (4) ◽  
pp. 300-302 ◽  
Author(s):  
Zorana Vasiljevic ◽  
Natasa Mickovski-Katalina ◽  
Gordana Krljanac ◽  
Gordana Panic ◽  
Biljana Putnikovic ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Primary Percutaneous Coronary Intervention ◽  
Coronary Care Unit ◽  
Standard Of Care ◽  
Coronary Intervention ◽  
Reperfusion Therapy ◽  
Percutaneous Coronary ◽  
St Elevation ◽  
Coronary Care

COVID-19 and Primary Percutaneous Coronary Intervention (PCI): Delayed Presentations and Outcomes for STEMI care

2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Zouina Sarfraz ◽  
Azza Sarfraz ◽  
Muzna Sarfraz ◽  
Zainab Nadeem ◽  
Hafiza Hussain ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Patient Outcomes ◽  
Primary Percutaneous Coronary Intervention ◽  
Coronary Intervention ◽  
Reperfusion Therapy ◽  
Treatment Delays ◽  
The Public ◽  
Percutaneous Coronary ◽  
St Elevation

Primary percutaneous coronary intervention (PPCI) is a non-surgical procedure that requires catheterization to improve blood flow to the heart and is the recommended therapy for Acute Myocardial Infarction (AMI). The Coronavirus 2019 (COVID-19) pandemic has altered the course of reperfusion therapy for patients with ST-elevation myocardial infarction (STEMI). It is imperative to emphasize the awareness of timely PCI and the effects it has on improving patient outcomes. Based on the consensus statement by the American College of Cardiology (ACC), American College for Emergency Physicians (ACEP), and the Society for Cardiovascular Angiography and Interventions (SCAI), it is critical to inform the public to call the emergency medical system for AMI symptoms and obtain the appropriate level of care. Ultimately, COVID-19 has posed unprecedented challenges to public health. The immediate threat is linked to morbidity and mortality related to the infection, and the masked threat is the waning attention and resources utilized for the care of other diseases. First medical contact is the main time target, and reducing treatment delays to improve patient outcomes in AMI patients with STEMI should be the next immediate objective in healthcare systems worldwide.

scholarly journals Primary Percutaneous Coronary Intervention (Primary PCI), Senjata "Baru" Untuk Melawan Serangan Jantung Akut

2013 ◽  
Vol 1 (2) ◽  
Author(s):  
Sodiqur Rifki
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Primary Percutaneous Coronary Intervention ◽  
Coronary Care Unit ◽  
Coronary Intervention ◽  
Primary Pci ◽  
Percutaneous Coronary ◽  
Coronary Care ◽  
Data Register

Serangan jantung akut atau infark miokard akut (acute myocardial infarction) adalah suatu momok yang mengerikan. Keluhan nyeri dadanya begitu menakutkan sehingga bisa membuat seorang perokok fanatik yang sudah puluhan tahun merokok dan tidak pernah mau mendengar saran dari siapapun, termasuk cucunya, tiba- tiba mau berhenti merokok seketika. Seorang yang pernah mengalami serangan ini mengatakan bahwa rasa ajal mau menjemput (feeling of death) itu begitu menakutkan, sehingga membuatnya tak ingin mengalaminya lagi. Dari semua pasien infark miokard, 25–35% akan meninggal sebelum mendapat pengobatan, umumnya disebabkan oleh gangguan irama jantung yang letal, yaitu fibrilasi ventrikel.1,2 Pasien yang berhasil sampai ke rumah sakit dari tahun ke tahun semakin menurun angka kematiannya. Penurunan tersebut terjadi karena beberapa hal, terutama sejak adanya perawatan CCU (Coronary Care Unit) dan dikembangkannya terapi reperfusi baik secara farmakologis dengan obat fibrinolitik maupun reperfusi mekanik dengan percutaneous coronary intervention (PCI). Sayangnya, data nasional Indonesia belum ada, tetapi analisis data register nasional di Amerika Serikat menunjukkan penurunan angka kematian pasien infark miokard yang mendapatkan terapi reperfusi jauh lebih rendah (5,7%), dibandingkan dengan yang tidak mendapatkan terapi reperfusi (14.8%).

Sign in / Sign up

Export Citation Format

Share Document